Overview

Progression Delaying Effect of Escitalopram in Alzheimer's Disease

Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
This study aimed to test whether escitalopram would slow the brain atrophy in patients with mild to moderate AD over the 52-week period.
Phase:
N/A
Details
Lead Sponsor:
Seoul National University Hospital
Collaborator:
H. Lundbeck A/S
Treatments:
Citalopram
Dexetimide